Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

Background: The novel and highly effective CFTR modulator combination of elexacaftor-tezacaftor-ivacaftor (ETI) has been shown to improve lung function and body weight in people with Cystic Fibrosis (pwCF) carrying a F508del mutation. However, the impact of these modulators on gastrointestinal (GI)...

詳細記述

保存先:
書誌詳細
主要な著者: Jochen G. Mainz (著者), Carlos Zagoya (著者), Louise Polte (著者), Lutz Naehrlich (著者), Lenny Sasse (著者), Olaf Eickmeier (著者), Christina Smaczny (著者), Anton Barucha (著者), Lilith Bechinger (著者), Franziska Duckstein (著者), Ludwik Kurzidim (著者), Patience Eschenhagen (著者), Laura Caley (著者), Daniel Peckham (著者), Carsten Schwarz (著者)
フォーマット: 図書
出版事項: Frontiers Media S.A., 2022-06-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可